Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
127657-97-0
13807-91-5
14690-00-7
622-08-2
85483-97-2
70448-03-2
379-50-0 | Triphenylfluorosilane | AA003V2V | MFCD00017899
55598-85-1 | Vancomycin CDP-1 | AA003V7R
4468-48-8 | α-Acetylphenylacetonitrile | AA003VCW | MFCD00001867
891782-63-1 | 5-Boc-amino-pyrazine-2-carboxylic acid | AA003W6Z | MFCD08437666
898289-31-1 | 2-(Tetrahydropyran-4-yloxy)benzaldehyde | AA003XMM | MFCD09064958
89108-45-2 | 5-Chloronaphthalene-2-sulfonyl chloride | AA003ZR0 | MFCD00269950
89044-79-1 | 7-Phenyl-1,4-diazepan-5-one | AA0041NW | MFCD12197004
889939-79-1 | (4-(4-Fluorophenyl)tetrahydro-2H-pyran-4-yl)methanamine | AA0043XN | MFCD08144102
885278-42-2 | Methyl 6-bromo-1H-indazole-3-carboxylate | AA0045CK | MFCD07371573
883-44-3 | N-(3-Hydroxypropyl)phthalimide | AA0046M5 | MFCD00023097